Albemarle Corporation
ALB
$0.00
-0.59%
Albemarle Corporation is a global leader in the specialty chemicals industry, primarily focused on lithium and bromine production. It is a fully integrated lithium producer with a core advantage stemming from its diversified upstream resources and global refining footprint, positioning it as a key supplier for the electric vehicle battery market.…
ALB
Albemarle Corporation
$0.00
Related headlines
ALB 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Albemarle Corporation's 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
7 analysts
Implied Upside
—
vs. current price
Analyst Count
7
covering this stock
Price Range
$0 - $0
Analyst target range
No sufficient analyst coverage available. The provided data includes recent rating actions from various firms but does not contain a consensus target price or a detailed ratings distribution summary. The institutional ratings show a mix of Buy, Outperform, Neutral, and Equal Weight actions from February 2026.
ALB Technical Analysis
Overall Assessment: The stock has exhibited a strong uptrend over the past six months, with a gain of 104.92%, significantly outperforming the broader market (SPY -2.82%). The price has more than tripled from its 52-week low of $49.43, demonstrating substantial recovery momentum.
Short-term Performance: Over the last three months, the stock is up 26.93%, again strongly outperforming the SPY's decline of 4.63%. In the most recent month, it gained 0.48%, which, while modest, still represents a positive relative strength of 5.73% compared to the market's 5.25% drop.
Current Position: The current price of $179.53 sits near the upper end of its 52-week range ($49.43 - $206.00), approximately 13% below the yearly high. The recent price action shows volatility, with a notable pullback from highs near $195 in late February, but the stock has stabilized in the $170-$180 range in March.
Beta
1.48
1.48x market volatility
Max Drawdown
-36.1%
Largest decline past year
52-Week Range
$49-$206
Price range past year
Annual Return
+148.5%
Cumulative gain past year
| Period | ALB Return | S&P 500 |
|---|---|---|
| 1m | +0.2% | -3.7% |
| 3m | +26.2% | -4.1% |
| 6m | +102.3% | -2.1% |
| 1y | +148.5% | +16.1% |
| ytd | +24.0% | -3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALB Fundamental Analysis
Revenue & Profitability: Revenue for Q4 2025 was $1.43 billion, representing a 15.9% year-over-year growth. However, profitability remains under pressure, with the company reporting a net loss of $414.2 million for the quarter, translating to a negative net margin of -29.0%. This continues a trend of volatile quarterly results, with net income swinging between positive and negative figures over the past year.
Financial Health: The balance sheet appears solid with a strong current ratio of 2.23 and a moderate debt-to-equity ratio of 0.35. Cash flow generation is healthy, with trailing twelve-month free cash flow of $692.5 million, providing financial flexibility.
Operational Efficiency: Operational metrics show challenges. Return on Equity (ROE) is negative at -5.36%, and Return on Assets (ROA) is a minimal 0.3%. The gross margin for the latest quarter was 14.2%, reflecting ongoing pressure on pricing and costs within the lithium market.
Quarterly Revenue
$1.4B
2025-12
Revenue YoY Growth
+0.15%
YoY Comparison
Gross Margin
+0.14%
Latest Quarter
Free Cash Flow
$692466000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALB Overvalued?
Valuation Level: Given the company's negative net income and EPS of -$0.03, the trailing P/E ratio of -32.6 is not meaningful. Therefore, the price-to-sales (PS) ratio of 3.24 is a more appropriate valuation metric. The forward P/E of 20.5, based on estimated future profitability, suggests the market is pricing in a significant earnings recovery.
Peer Comparison: Data not available for a direct industry average comparison. The valuation appears to be forward-looking, anticipating a rebound in lithium prices and the company's profitability, as reflected in the PEG ratio of 0.67, which suggests the stock may be undervalued relative to its expected earnings growth.
PE
-32.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -1788x~1549x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.3x
Enterprise Value Multiple

